Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases

BACKGROUND: Acquired hemophilia A (AHA) is a rare autoimmune disease characterized by bleeding events. Recombinant activated factor VII (rFVIIa) is a first-line bypassing agent, which is effective against clinically significant bleeding. However, there is no standard way of tapering and discontinuin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosoi, Hiroki, Akagi, Yuina, Mushino, Toshiki, Takeyama, Masahiro, Minoura, Naoto, Hiroi, Takayuki, Furuya, Yoshiaki, Morimoto, Masaya, Murata, Shogo, Tamura, Shinobu, Sonoki, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109301/
https://www.ncbi.nlm.nih.gov/pubmed/35578257
http://dx.doi.org/10.1186/s12959-022-00387-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109301/
https://www.ncbi.nlm.nih.gov/pubmed/35578257
http://dx.doi.org/10.1186/s12959-022-00387-x

Ejemplares similares